{"count": 2, "results": [{"_id": "39831954", "pmid": 39831954, "title": "Blood Pressure Control and Incident Left-Ventricular Conduction Disease.", "journal": "Curr Cardiol Rep", "authors": ["Frimodt-Møller EK", "Marcus GM"], "date": "2025-01-20T00:00:00Z", "doi": "10.1007/s11886-025-02196-w", "meta_date_publication": "2025 Jan 20", "meta_volume": "27", "meta_issue": "1", "meta_pages": "29", "score": 50245.83, "text_hl": "In randomized trials, intensive blood pressure control among @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ individuals reduced the incidence of @DISEASE_Ventricular_Dysfunction_Left @DISEASE_MESH:D018487 @@@left-ventricular conduction abnormalities@@@ in the form of @DISEASE_Bundle_Branch_Block @DISEASE_MESH:D002037 @@@fascicular- and left bundle branch blocks@@@, while treatment with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ independent of blood pressure control appeared to reduce @<m>DISEASE_Disease</m> @DISEASE_MESH:D004194 @@@conduction disease@@@ risk. ", "citations": {"NLM": "Frimodt-Møller EK, Marcus GM. Blood Pressure Control and Incident Left-Ventricular Conduction Disease. Curr Cardiol Rep. 2025 Jan 20;27(1):29. PMID: 39831954", "BibTeX": "@article{39831954, title={Blood Pressure Control and Incident Left-Ventricular Conduction Disease.}, author={Frimodt-Møller EK and Marcus GM}, journal={Curr Cardiol Rep}, volume={27}, number={1}, pages={29}}"}}, {"_id": "11328901", "pmid": 11328901, "title": "Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.", "journal": "Nephrol Dial Transplant", "authors": ["Cinotti GA", "Zucchelli PC", "Collaborative Study Group"], "date": "2001-05-01T00:00:00Z", "doi": "10.1093/ndt/16.5.961", "meta_date_publication": "2001 May", "meta_volume": "16", "meta_issue": "5", "meta_pages": "961-6", "score": 50052.785, "text_hl": "One hundred and thirty-one @SPECIES_9606 @@@patients@@@ with @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@chronic renal insufficiency@@@ (Clcr between 20-50 ml/min) because of primary @<m>DISEASE_Disease</m> @DISEASE_MESH:D004194 @@@renoparenchymal diseases@@@ and @DISEASE_Proteinuria @DISEASE_MESH:D011507 @@@proteinuria@@@ < or =1.0 g/day, were randomized to @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ (L=66) or alternative antihypertensive therapy (C=65). ", "citations": {"NLM": "Cinotti GA, Zucchelli PC, Collaborative Study Group. Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies. Nephrol Dial Transplant. 2001 May;16(5):961-6. PMID: 11328901", "BibTeX": "@article{11328901, title={Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.}, author={Cinotti GA and Zucchelli PC and Collaborative Study Group}, journal={Nephrol Dial Transplant}, volume={16}, number={5}, pages={961-6}}"}}]}